Effects of perioperative esketamine infusion on chronic pain after video-assisted thoracoscopic lung resection: a multicentre, randomised, double-blind clinical trial
Skip to main content
eScholarship
Open Access Publications from the University of California

UC Davis

UC Davis Previously Published Works bannerUC Davis

Effects of perioperative esketamine infusion on chronic pain after video-assisted thoracoscopic lung resection: a multicentre, randomised, double-blind clinical trial

Abstract

BACKGROUND: Chronic postsurgical pain after thoracoscopic surgery remains common. We investigated whether perioperative low-dose esketamine infusion would reduce chronic pain after video-assisted thoracoscopic lung resection. METHODS: In this multicentre, randomised controlled trial, 914 adults were randomly assigned (1:1) to receive either esketamine or normal saline. Esketamine was administered as a 0.1 mg kg-1 bolus at induction, followed by continuous intraoperative infusion (0.1 mg kg-1 h-1) and postoperative infusion (0.015 mg kg-1 h-1) for 48 h. The primary outcome was chronic pain at 3 months, defined as persistent pain with a numeric rating scale score ≥1 during coughing in the surgical region. Secondary outcomes included postoperative pain, supplemental analgesics use, recovery of bowel function, in-hospital adverse events, and esketamine-related side-effects. RESULTS: We analysed 873 patients (median age, 55 yr; 63% female). The incidence of 3 month chronic pain was lower in the esketamine group than in the control group (14.7% vs 21.2%; adjusted odds ratio, 0.62; 95% confidence interval, 0.43-0.90; P=0.013). A reduction was also observed when using a post hoc outcome definition of a numeric rating scale pain score ≥3 during coughing at 3 months (adjusted odds ratio, 0.39; 95% confidence interval, 0.19-0.84; P=0.015). Esketamine also reduced overall pain scores at rest and during coughing within the first 48 h, and decreased supplemental analgesic requirements within 48 h and 3 months. CONCLUSIONS: Perioperative low-dose esketamine infusion significantly reduced 3 month chronic pain after thoracoscopic lung resection without increasing adverse effects. CLINICAL TRIAL REGISTRATION: ChiCTR2000040012. TRIAL REGISTRATION: This trial was registered on the Chinese Clinical Trial Registry (Identifier: ChiCTR2000040012; principal investigator: Fu-hai Ji; dated November 18, 2020; https://www.chictr.org.cn/showprojEN.html?proj=62319).

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.